ClearSign Technologies Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ClearSign Technologies Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $0 | Mar 12, 2019 |
| FY2018 | Sep 30, 2018 | $0 | Mar 12, 2019 |
| FY2018 | Jun 30, 2018 | $0 | Mar 12, 2019 |
| FY2018 | Mar 31, 2018 | $530.0K | Mar 12, 2019 |
| FY2018 | Dec 31, 2017 | $180.0K | Mar 12, 2019 |
| FY2018 | Sep 30, 2017 | $0 | Mar 12, 2019 |
| FY2018 | Jun 30, 2017 | $0 | Mar 12, 2019 |
| FY2018 | Mar 31, 2017 | $360.0K | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | $361.0K | Mar 27, 2018 |
| FY2017 | Sep 30, 2016 | $260.0K | Mar 27, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($1.16M) | Mar 31, 2025 |
| FY2024 | Sep 30, 2024 | ($1.16M) | Mar 31, 2025 |
| FY2024 | Jun 30, 2024 | ($1.87M) | Mar 31, 2025 |
| FY2024 | Mar 31, 2024 | ($1.11M) | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | ($955.0K) | Mar 31, 2025 |
| FY2024 | Sep 30, 2023 | ($1.33M) | Mar 31, 2025 |
| FY2024 | Jun 30, 2023 | ($1.48M) | Mar 31, 2025 |
| FY2024 | Mar 31, 2023 | ($1.43M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($1.32M) | Apr 1, 2024 |
| FY2023 | Sep 30, 2022 | ($1.31M) | Apr 1, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($6.49M) | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | ($5.98M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($6.12M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($8.15M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($6.93M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($8.58M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($9.57M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($9.71M) | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | ($11.21M) | Mar 27, 2018 |
| FY2016 | Dec 31, 2015 | ($7.94M) | Feb 14, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $15.92M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $7.62M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $10.93M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $9.36M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $11.12M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $10.94M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $18.64M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $4.16M | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | $4.29M | Mar 27, 2018 |
| FY2016 | Dec 31, 2015 | $14.20M | Feb 14, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.15M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $2.43M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.37M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.08M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.58M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.72M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.73M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $1.73M | Mar 12, 2019 |
| FY2017 | Dec 31, 2016 | $2.04M | Mar 27, 2018 |
| FY2015 | Dec 31, 2015 | $1.62M | Mar 3, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $8.28M | Mar 31, 2022 |
| FY2021 | Dec 31, 2020 | $9.54M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $9.22M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $16.91M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.43M | Mar 12, 2019 |
| FY2018 | Dec 31, 2016 | $2.24M | Mar 12, 2019 |
| FY2017 | Dec 31, 2015 | $12.58M | Mar 27, 2018 |
| FY2016 | Dec 31, 2014 | $2.96M | Feb 14, 2017 |
| FY2015 | Dec 31, 2013 | $3.79M | Mar 3, 2016 |
| FY2014 | Dec 31, 2012 | $8.64M | Feb 26, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 31, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Mar 31, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Mar 31, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 31, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Mar 31, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Apr 1, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Mar 31, 2025 |
| FY2024 | Sep 30, 2024 | 0 | Mar 31, 2025 |
| FY2024 | Jun 30, 2024 | 0 | Mar 31, 2025 |
| FY2024 | Mar 31, 2024 | 0 | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 31, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Mar 31, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Apr 1, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $14.04M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $5.68M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $6.45M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $7.61M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $8.82M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $8.55M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $8.95M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $1.25M | Mar 12, 2019 |
| FY2018 | Dec 31, 2016 | $1.26M | Mar 12, 2019 |
| FY2017 | Dec 31, 2015 | $10.99M | Mar 27, 2018 |